Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom
- PMID: 30653221
- DOI: 10.1001/jamaoncol.2018.6501
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom
Comment in
-
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.JAMA Oncol. 2019 Mar 1;5(3):428-429. doi: 10.1001/jamaoncol.2018.6504. JAMA Oncol. 2019. PMID: 30653219 No abstract available.
Comment on
-
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.JAMA Oncol. 2018 Nov 1;4(11):1504-1510. doi: 10.1001/jamaoncol.2018.1901. JAMA Oncol. 2018. PMID: 29978189 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
